Right here, we explored whether or not a minicircle DNA (MC) vector containing human angiopoietin 1 (MC-ANGPT1) can present a more practical platform for gene-enhanced MSC remedy of ALI/ARDS. At 24 h after transfection, nuclear-targeted electroporation utilizing an MC-ANGPT1 vector resulted in a 3.7-fold better enhance in human ANGPT1 protein in MSC conditioned media in comparison with the usage of a plasmid ANGPT1 vector. Within the lipopolysaccharide (LPS)-induced ALI mannequin, administration of pANGPT1 transfected MSCs considerably decreased bronchoalveolar lavage (BAL) neutrophil counts by 57%, whereas MC-ANGPT1 transfected MSCs decreased it by 71% (p < 0.001) by Holm-Sidak’s a number of comparability take a look at.
Furthermore, in comparison with pANGPT1, the MC-ANGPT1 transfected MSCs considerably decreased pulmonary irritation, as noticed in decreased ranges of proinflammatory cytokines, akin to tumor necrosis factor-alpha (TNF-α), interferon-gamma (IFN-γ), interleukin-6 (IL-6), monocyte chemoattractant protein-1 (MCP-1), and macrophage inflammatory protein-2 (MIP-2). pANGPT1-transfected MSCs considerably decreased BAL albumin ranges by 71%, whereas MC-ANGPT1-transfected MSCs decreased it by 85%. Total, utilizing a minicircle vector, we demonstrated an environment friendly and sustained expression of the ANGPT1 transgene in MSCs and enhanced the therapeutic impact on the ALI mannequin in comparison with plasmid.
Plasmid Vectors for in Vivo Choice-Free Use with the Probiotic E. coli Nissle 1917
Escherichia coli Nissle 1917 (EcN) is a probiotic bacterium, generally employed to deal with sure gastrointestinal issues. It’s quick rising as an essential goal for the event of therapeutic engineered micro organism, benefiting from the wealth of information of E. coli biology and ease of manipulation. Bacterial artificial biology initiatives generally make the most of engineered plasmid vectors, that are easy to engineer and might reliably obtain excessive ranges of protein expression. Nevertheless, plasmids usually require antibiotics for upkeep, and the administration of an antibiotic is commonly incompatible with in vivo experimentation or remedy.
EcN natively accommodates plasmids pMUT1 and pMUT2, which don’t have any recognized operate however are secure inside the micro organism. Right here, we describe the event of the pMUT plasmids into a strong platform for engineering EcN for in vivo experimentation, alongside a CRISPR-Cas9 system to take away the native plasmids. We systematically engineered each pMUT plasmids to include choice markers, fluorescent markers, temperature delicate expression, and curli secretion programs to export a customizable purposeful materials into the extracellular area.
We then reveal that the engineered plasmids had been maintained in micro organism because the engineered micro organism go by the mouse GI tract with out choice, and that the secretion system stays purposeful, exporting functionalized curli proteins into the intestine. Our plasmid system presents a platform for the fast improvement of therapeutic EcN micro organism.
Cloning in Plasmid Vectors: Blunt-Finish Cloning
This protocol describes procedures for cloning blunt-ended DNA fragments into linearized plasmid vectors. To acquire the utmost variety of “appropriate” ligation merchandise when cloning blunt-ended goal fragments, the 2 elements of DNA within the ligation response have to be current at an acceptable ratio. These outcomes assist the potential advantages of MC-ANGPT1 gene enhancement of MSC remedy to deal with ARDS.
If the molar ratio of plasmid vector to focus on DNA is just too excessive, then the ligation response might generate an undesirable variety of round empty plasmids, each monomeric and polymeric; if too low, the ligation response might generate an extra of linear and round homopolymers and heteropolymers of various sizes, orientations, and compositions. Because of this, the orientation of the overseas DNA and the variety of inserts in every recombinant clone should at all times be validated by restriction endonuclease mapping or another means.
Plasmid copy quantity variation of a modular vector set in Shewanella oneidensis MR-1
To advance artificial biology approaches that make the most of S. oneidensis as host for biotechnology functions, now we have investigated the variation in plasmid copy variety of a modular vector set ensuing from distinct origins of replication beneath totally different circumstances. The replicons yielded a ≈9X-fold vary for plasmid copy quantity variation in S. oneidensis (whereas the identical origins yielded a ≈3X-fold vary in Escherichia coli). This offers a sizeable vary to regulate gene expression ranges in S. oneidensis for artificial biology functions. As well as, plasmid harboring the pBBR1 origin resulted in secure copy numbers in S. oneidensis beneath totally different circumstances (mid-logarithmic, stationary, multi-plasmid).
Human Transcription factor p65 protein (NFKB3) |
|||
| 1-CSB-RP039874h | Cusabio |
|
|
|
Description: Recombinant Human Transcription factor p65 protein(NFKB3),partial expressed in E.coli |
|||
Rat Transcription factor p65 / NFKB3 (RELA) ELISA Kit |
|||
| 20-abx156040 | Abbexa |
|
|
Human Transcription factor p65 / NFKB3 (RELA) ELISA Kit |
|||
| 20-abx152945 | Abbexa |
|
|
Chicken Transcription factor p65 / NFKB3 (RELA) ELISA Kit |
|||
| abx357192-96tests | Abbexa | 96 tests | EUR 990 |
Monkey Transcription factor p65 / NFKB3 (RELA) ELISA Kit |
|||
| abx359107-96tests | Abbexa | 96 tests | EUR 990 |
Rabbit Transcription factor p65 / NFKB3 (RELA) ELISA Kit |
|||
| abx362582-96tests | Abbexa | 96 tests | EUR 990 |
Sheep Transcription factor p65 / NFKB3 (RELA) ELISA Kit |
|||
| abx364265-96tests | Abbexa | 96 tests | EUR 1111.2 |
Pig Transcription factor p65 / NFKB3 (RELA) ELISA Kit |
|||
| abx361108-96tests | Abbexa | 96 tests | EUR 990 |
Human Transcription factor p65 / NFKB3 (RELA) ELISA Kit |
|||
| abx252815-96tests | Abbexa | 96 tests | EUR 801.6 |
Mouse Transcription factor p65 / NFKB3 (RELA) ELISA Kit |
|||
| abx254289-96tests | Abbexa | 96 tests | EUR 801.6 |
Human Transcription factor p65 / NFKB3 (RELA) ELISA Kit |
|||
| abx570125-96tests | Abbexa | 96 tests | EUR 801.6 |
Mouse Transcription factor p65 / NFKB3 (RELA) ELISA Kit |
|||
| abx570127-96tests | Abbexa | 96 tests | EUR 801.6 |
Rat Transcription factor p65 / NFKB3 (RELA) ELISA Kit |
|||
| abx255851-96tests | Abbexa | 96 tests | EUR 801.6 |
Guinea pig Transcription factor p65 / NFKB3 (RELA) ELISA Kit |
|||
| abx357262-96tests | Abbexa | 96 tests | EUR 990 |
Anti-Anti-SEPT6 antibody antibody |
|||
| STJ11100949 | St John's Laboratory | 100 µl | EUR 332.4 |
|
Description: This gene is a member of the septin family of GTPases. Members of this family are required for cytokinesis. One version of pediatric acute myeloid leukemia is the result of a reciprocal translocation between chromosomes 11 and X, with the breakpoint associated with the genes encoding the mixed-lineage leukemia and septin 2 proteins. This gene encodes four transcript variants encoding three distinct isoforms. An additional transcript variant has been identified, but its biological validity has not been determined. |
|||
Anti-Anti-SEPT9 Antibody antibody |
|||
| STJ111369 | St John's Laboratory | 100 µl | EUR 332.4 |
|
Description: This gene is a member of the septin family involved in cytokinesis and cell cycle control. This gene is a candidate for the ovarian tumor suppressor gene. Mutations in this gene cause hereditary neuralgic amyotrophy, also known as neuritis with brachial predilection. A chromosomal translocation involving this gene on chromosome 17 and the MLL gene on chromosome 11 results in acute myelomonocytic leukemia. Multiple alternatively spliced transcript variants encoding different isoforms have been described. |
|||
Anti-Anti-SEPT11 Antibody antibody |
|||
| STJ111530 | St John's Laboratory | 100 µl | EUR 332.4 |
Anti-Anti-SEPT4 Antibody antibody |
|||
| STJ112276 | St John's Laboratory | 100 µl | EUR 332.4 |
|
Description: This gene is a member of the septin family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse, and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. This gene is highly expressed in brain and heart. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. One of the isoforms (known as ARTS) is distinct; it is localized to the mitochondria, and has a role in apoptosis and cancer. |
|||
Anti-Anti-MARCH9 Antibody antibody |
|||
| STJ112609 | St John's Laboratory | 100 µl | EUR 332.4 |
Anti-Anti-SEPT11 Antibody antibody |
|||
| STJ113941 | St John's Laboratory | 100 µl | EUR 332.4 |
Anti-Anti-SEPT11 Antibody antibody |
|||
| STJ114081 | St John's Laboratory | 100 µl | EUR 332.4 |
Anti-Anti-SEPT5 Antibody antibody |
|||
| STJ114819 | St John's Laboratory | 100 µl | EUR 332.4 |
|
Description: This gene is a member of the septin gene family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. This gene is mapped to 22q11, the region frequently deleted in DiGeorge and velocardiofacial syndromes. A translocation involving the MLL gene and this gene has also been reported in patients with acute myeloid leukemia. Alternative splicing results in multiple transcript variants. The presence of a non-consensus polyA signal (AACAAT) in this gene also results in read-through transcription into the downstream neighboring gene (GP1BB; platelet glycoprotein Ib), whereby larger, non-coding transcripts are produced. |
|||
Anti-Anti-MARCH8 Antibody antibody |
|||
| STJ114828 | St John's Laboratory | 100 µl | EUR 332.4 |
Anti-Anti-SEPT7 Antibody antibody |
|||
| STJ116214 | St John's Laboratory | 100 µl | EUR 332.4 |
|
Description: This gene encodes a protein that is highly similar to the CDC10 protein of Saccharomyces cerevisiae. The protein also shares similarity with Diff 6 of Drosophila and with H5 of mouse. Each of these similar proteins, including the yeast CDC10, contains a GTP-binding motif. The yeast CDC10 protein is a structural component of the 10 nm filament which lies inside the cytoplasmic membrane and is essential for cytokinesis. This human protein functions in gliomagenesis and in the suppression of glioma cell growth, and it is required for the association of centromere-associated protein E with the kinetochore. Alternative splicing results in multiple transcript variants. Several related pseudogenes have been identified on chromosomes 5, 7, 9, 10, 11, 14, 17 and 19. |
|||
Anti-Anti-SEPT8 Antibody antibody |
|||
| STJ117206 | St John's Laboratory | 100 µl | EUR 332.4 |
|
Description: This gene is a member of the septin family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse, and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. |
|||
Anti-Anti-SEPT12 Antibody antibody |
|||
| STJ117759 | St John's Laboratory | 100 µl | EUR 332.4 |
|
Description: This gene encodes a guanine-nucleotide binding protein and member of the septin family of cytoskeletal GTPases. Septins play important roles in cytokinesis, exocytosis, embryonic development, and membrane dynamics. Multiple transcript variants encoding different isoforms have been found for this gene. |
|||
Anti-Anti-MARCH6 Antibody antibody |
|||
| STJ118549 | St John's Laboratory | 100 µl | EUR 332.4 |
Anti-Anti-MARCH6 Antibody antibody |
|||
| STJ118550 | St John's Laboratory | 100 µl | EUR 332.4 |
Anti-Anti-MARCH7 Antibody antibody |
|||
| STJ118752 | St John's Laboratory | 100 µl | EUR 332.4 |
Anti-Anti-SEPT3 Antibody antibody |
|||
| STJ118990 | St John's Laboratory | 100 µl | EUR 332.4 |
Anti-Anti-SEPT2 Antibody antibody |
|||
| STJ28365 | St John's Laboratory | 100 µl | EUR 332.4 |
Anti-Anti-SEPT7 Antibody antibody |
|||
| STJ28963 | St John's Laboratory | 100 µl | EUR 332.4 |
|
Description: This gene encodes a protein that is highly similar to the CDC10 protein of Saccharomyces cerevisiae. The protein also shares similarity with Diff 6 of Drosophila and with H5 of mouse. Each of these similar proteins, including the yeast CDC10, contains a GTP-binding motif. The yeast CDC10 protein is a structural component of the 10 nm filament which lies inside the cytoplasmic membrane and is essential for cytokinesis. This human protein functions in gliomagenesis and in the suppression of glioma cell growth, and it is required for the association of centromere-associated protein E with the kinetochore. Alternative splicing results in multiple transcript variants. Several related pseudogenes have been identified on chromosomes 5, 7, 9, 10, 11, 14, 17 and 19. |
|||
Anti-Anti-SEPT2 Antibody antibody |
|||
| STJ25475 | St John's Laboratory | 100 µl | EUR 332.4 |
Anti-Anti-SEPT5 Antibody antibody |
|||
| STJ25477 | St John's Laboratory | 100 µl | EUR 332.4 |
|
Description: This gene is a member of the septin gene family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. This gene is mapped to 22q11, the region frequently deleted in DiGeorge and velocardiofacial syndromes. A translocation involving the MLL gene and this gene has also been reported in patients with acute myeloid leukemia. Alternative splicing results in multiple transcript variants. The presence of a non-consensus polyA signal (AACAAT) in this gene also results in read-through transcription into the downstream neighboring gene (GP1BB; platelet glycoprotein Ib), whereby larger, non-coding transcripts are produced. |
|||
Anti-Anti-SEPT8 Antibody antibody |
|||
| STJ25479 | St John's Laboratory | 100 µl | EUR 332.4 |
|
Description: This gene is a member of the septin family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse, and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. |
|||
Anti-Anti-SEPT1 antibody antibody |
|||
| STJ119580 | St John's Laboratory | 100 µl | EUR 332.4 |
|
Description: This gene is a member of the septin family of GTPases. Members of this family are required for cytokinesis and the maintenance of cellular morphology. This gene encodes a protein that can form homo- and heterooligomeric filaments, and may contribute to the formation of neurofibrillary tangles in Alzheimer's disease. Alternatively spliced transcript variants have been found but the full-length nature of these variants has not been determined. [provided by RefSeq, Dec 2012] |
|||
Anti-Anti-DDB1 Antibody |
|||
| A00333 | BosterBio | 100uL | EUR 546 |
|
Description: Rabbit Polyclonal DDB1 Antibody. Validated in IP and tested in Human, Mouse. |
|||
Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) ELISA Kit |
|||
| AEA465Hu-10x96wellstestplate | Cloud-Clone | 10x96-wells test plate | EUR 6777.36 |
|
Description: This is Competitive Enzyme-linked immunosorbent assay for Antibody Detection.detection of Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) in serum, plasma and other biological fluids. |
|||
Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) ELISA Kit |
|||
| AEA465Hu-1x48wellstestplate | Cloud-Clone | 1x48-wells test plate | EUR 663.31 |
|
Description: This is Competitive Enzyme-linked immunosorbent assay for Antibody Detection.detection of Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) in serum, plasma and other biological fluids. |
|||
Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) ELISA Kit |
|||
| AEA465Hu-1x96wellstestplate | Cloud-Clone | 1x96-wells test plate | EUR 896.16 |
|
Description: This is Competitive Enzyme-linked immunosorbent assay for Antibody Detection.detection of Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) in serum, plasma and other biological fluids. |
|||
Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) ELISA Kit |
|||
| AEA465Hu-5x96wellstestplate | Cloud-Clone | 5x96-wells test plate | EUR 3672.72 |
|
Description: This is Competitive Enzyme-linked immunosorbent assay for Antibody Detection.detection of Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) in serum, plasma and other biological fluids. |
|||
Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) ELISA Kit |
|||
| 4-AEA465Hu | Cloud-Clone |
|
|
|
Description: Enzyme-linked immunosorbent assay based on the Competitive Inhibition method for detection of Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) in samples from serum, plasma and other biological fluids with no significant corss-reactivity with analogues from other species. |
|||
ELISA kit for Human Anti-AsAb (Anti-Anti-Sperm Antibody Antibody) |
|||
| ELK8071 | ELK Biotech | 1 plate of 96 wells | EUR 518.4 |
|
Description: A competitive Inhibition ELISA kit for detection of Anti-Anti-Sperm Antibody Antibody from Human in samples from blood, serum, plasma, cell culture fluid and other biological fluids. |
|||
Anti-ZNF660 antibody |
|||
| 44742-100ul | SAB | 100ul | EUR 302.4 |
Anti-ZNF660 antibody |
|||
| 44742-50ul | SAB | 50ul | EUR 224.4 |
Anti-CCV Antibody |
|||
| 10-2789 | Fitzgerald | 1 mg | EUR 217.2 |
|
Description: Anti-Canine Corona Virus Antibody |
|||
Anti-CCV Antibody |
|||
| 10-2790 | Fitzgerald | 1 mg | EUR 217.2 |
|
Description: Anti-Canine Corona Virus Antibody |
|||
Anti-CDV antibody |
|||
| 10-2791 | Fitzgerald | 1 mg | EUR 198 |
|
Description: Anti-Canine Distemper Virus antibody |
|||
Anti-CDV antibody |
|||
| 10-2792 | Fitzgerald | 1 mg | EUR 198 |
|
Description: Anti-Canine Distemper Virus antibody |
|||
Anti-CDV antibody |
|||
| 10-2793 | Fitzgerald | 1 mg | EUR 198 |
|
Description: Anti-Canine Distemper Virus antibody |
|||
Anti-CDV antibody |
|||
| 10-2794 | Fitzgerald | 1 mg | EUR 198 |
|
Description: Anti-Canine Distemper Virus antibody |
|||
Anti-CPV Antibody |
|||
| 10-2795 | Fitzgerald | 500 uig | EUR 165.6 |
|
Description: Anti-Canine Parvo Virus Antibody |
|||
Anti-CPV Antibody |
|||
| 10-2796 | Fitzgerald | 500 ug | EUR 165.6 |
|
Description: Anti-Canine Parvo Virus Antibody |
|||
Anti-CPV Antibody |
|||
| 10-2797 | Fitzgerald | 500 ug | EUR 165.6 |
|
Description: Anti-Canine Parvo Virus Antibody |
|||
Anti-C.CRP antibody |
|||
| 10-2798 | Fitzgerald | 500 ug | EUR 165.6 |
|
Description: Anti-Canine CRP antibody |
|||
Anti-C.CRP antibody |
|||
| 10-2799 | Fitzgerald | 500 ug | EUR 165.6 |
|
Description: Anti-Canine CRP antibody |
|||
Anti-CHW antibody |
|||
| 10-2800 | Fitzgerald | 1 mg | EUR 198 |
|
Description: Anti-Canine Heartworm antibody |
|||
Anti-FeLV antibody |
|||
| 10-2801 | Fitzgerald | 1 mg | EUR 217.2 |
|
Description: Anti-Feline Leukemia Virus antibody |
|||
Anti-FeLV antibody |
|||
| 10-2802 | Fitzgerald | 1 mg | EUR 217.2 |
|
Description: Anti-Feline Leukemia Virus antibody |
|||
Anti-FeLV antibody |
|||
| 10-2803 | Fitzgerald | 1 mg | EUR 217.2 |
|
Description: Anti-Feline Leukemia Virus antibody |
|||
Anti-PGI antibody |
|||
| 10-2806 | Fitzgerald | 1 mg | EUR 502.8 |
|
Description: Anti-PGI recombinant antibody |
|||
Anti-PGI antibody |
|||
| 10-2807 | Fitzgerald | 1 mg | EUR 502.8 |
|
Description: Anti-PGI recombinant antibody |
|||
Anti-PGII antibody |
|||
| 10-2808 | Fitzgerald | 1 mg | EUR 502.8 |
|
Description: Anti-PGII recombinant antibody |
|||
Anti-PGII antibody |
|||
| 10-2809 | Fitzgerald | 1 mg | EUR 502.8 |
|
Description: Anti-PGII recombinant antibody |
|||
Anti-CHW antibody |
|||
| 10-2810 | Fitzgerald | 1 mg | EUR 198 |
|
Description: Anti-CHW monoclonal antibody |
|||
Anti-Giardia antibody |
|||
| 10-2811 | Fitzgerald | 1 mg | EUR 198 |
|
Description: Anti-Giardia monoclonal antibody |
|||
Anti-Giardia antibody |
|||
| 10-2812 | Fitzgerald | 1 mg | EUR 198 |
|
Description: Anti-Giardia monoclonal antibody |
|||
Anti-TAP1 Antibody |
|||
| A01123 | BosterBio | 100ul | EUR 476.4 |
|
Description: Rabbit Polyclonal TAP1 Antibody. Validated in IP, IHC, WB and tested in Human, Rat. |
|||
Anti-CHD4 Antibody |
|||
| A01125 | BosterBio | 100ul | EUR 476.4 |
|
Description: Rabbit Polyclonal CHD4 Antibody. Validated in IF, IHC and tested in Human, Mouse. |
|||
Anti-NRF1 Antibody |
|||
| A01129-2 | BosterBio | 100ug/vial | EUR 400.8 |
Anti-MEF2C Antibody |
|||
| A01131-1 | BosterBio | 100ug/vial | EUR 400.8 |
Anti-SCN4A Antibody |
|||
| A01138 | BosterBio | 100ul | EUR 476.4 |
|
Description: Rabbit Polyclonal SCN4A Antibody. Validated in WB and tested in Human. |
|||
Anti-MTR Antibody |
|||
| A01140-2 | BosterBio | 100ug/vial | EUR 400.8 |
Anti-IL12B Antibody |
|||
| A01152-2 | BosterBio | 100ug/vial | EUR 352.8 |
Anti-IL12B Antibody |
|||
| A01152-3 | BosterBio | 100ug/vial | EUR 400.8 |
Anti-IL12B Antibody |
|||
| A01152-4 | BosterBio | 100ug/vial | EUR 352.8 |
Anti-IL11 Antibody |
|||
| A01160-1 | BosterBio | 100ug/vial | EUR 352.8 |
Anti-Bak Antibody |
|||
| A01163 | BosterBio | 200ug | EUR 626.4 |
|
Description: Rabbit Polyclonal Bak Antibody. Validated in IP, IF, IHC, WB and tested in Human. |
|||
Anti-PGF Antibody |
|||
| A01164-1 | BosterBio | 100ug/vial | EUR 352.8 |
Anti-PGF Antibody |
|||
| A01164-2 | BosterBio | 100ug/vial | EUR 352.8 |
Anti-CD201 Antibody |
|||
| A01166 | BosterBio | 100ul | EUR 476.4 |
|
Description: Rabbit Polyclonal Antibody for CD201 Antibody (PROCR) detection.tested for IHC, WB in Human, Mouse, Rat. |
|||
Anti-SERCA2 Antibody |
|||
| A01176 | BosterBio | 100ul | EUR 476.4 |
|
Description: Rabbit Polyclonal Antibody for SERCA2 Antibody (ATP2A2) detection.tested for IHC, WB in Human, Mouse, Rat. |
|||
Anti-XPA Antibody |
|||
| A01182 | BosterBio | 100ul | EUR 476.4 |
|
Description: Rabbit Polyclonal XPA Antibody. Validated in IHC, WB and tested in Human. |
|||
Anti-XPA Antibody |
|||
| A01182-1 | BosterBio | 100ul | EUR 476.4 |
|
Description: Rabbit Polyclonal Antibody for XPA Antibody (XPA) detection.tested for WB in Human, Mouse. |
|||
Anti-XPA Antibody |
|||
| A01182-2 | BosterBio | 100ug/vial | EUR 352.8 |
Anti-BNP Antibody |
|||
| A01186-1 | BosterBio | 100ul | EUR 476.4 |
|
Description: Rabbit Polyclonal BNP Antibody. Validated in IF, IHC, WB and tested in Mouse, Rat. |
|||
Anti-CD1c Antibody |
|||
| A01188-1 | BosterBio | 100ug/vial | EUR 352.8 |
Anti-CDC7 Antibody |
|||
| A01190 | BosterBio | 100ul | EUR 476.4 |
|
Description: Rabbit Polyclonal CDC7 Antibody. Validated in WB and tested in Human. |
|||
Anti-VCAM1 Antibody |
|||
| A01199 | BosterBio | 100ug/vial | EUR 400.8 |
Anti-VCAM1 Antibody |
|||
| A01199-1 | BosterBio | 100ug/vial | EUR 352.8 |
Anti-VCAM1 Antibody |
|||
| A01199-2 | BosterBio | 100ug/vial | EUR 400.8 |
Anti-MAP2 Antibody |
|||
| A01201 | BosterBio | 100ug/vial | EUR 352.8 |
Anti-MAP2 Antibody |
|||
| A01201-1 | BosterBio | 100ul | EUR 476.4 |
|
Description: Rabbit Polyclonal MAP2 Antibody. Validated in IF, WB and tested in Human, Mouse, Rat. |
|||
Anti-RING1B Antibody |
|||
| A01209-1 | BosterBio | 100ug | EUR 546 |
|
Description: Goat Polyclonal RING1B Antibody. Validated in IF, WB and tested in Human, Mouse, Rat. |
|||
Anti-MUC2 Antibody |
|||
| A01212 | BosterBio | 100ug/vial | EUR 400.8 |
Anti-C1INH Antibody |
|||
| A01221 | BosterBio | 100ul | EUR 476.4 |
|
Description: Rabbit Polyclonal Antibody for C1INH Antibody (SERPING1) detection.tested for WB in Human. |
|||
Anti-WWOX Antibody |
|||
| A01223-1 | BosterBio | 100ug/vial | EUR 400.8 |
Anti-RNF168 Antibody |
|||
| A01224-1 | BosterBio | 100ug/vial | EUR 400.8 |
Anti-HDAC5 Antibody |
|||
| A01230-5 | BosterBio | 100ug/vial | EUR 400.8 |
Anti-Dysferlin Antibody |
|||
| A01234-1 | BosterBio | 100ul | EUR 476.4 |
|
Description: Rabbit Polyclonal Dysferlin Antibody. Validated in WB and tested in Human, Mouse. |
|||
Anti-LPP Antibody |
|||
| A01240-2 | BosterBio | 100ug/vial | EUR 400.8 |
Anti-p57 Antibody |
|||
| A01244 | BosterBio | 100ul | EUR 476.4 |
|
Description: Rabbit Polyclonal Antibody for p57 Antibody (CDKN1C) detection.tested for IHC, WB in Human, Mouse, Rat. |
|||
Anti-MDC1 Antibody |
|||
| A01252-2 | BosterBio | 100ug/vial | EUR 400.8 |
Anti-FHL Antibody |
|||
| A01258-1 | BosterBio | 100ug/vial | EUR 400.8 |
Anti-FHL Antibody |
|||
| A01258-2 | BosterBio | 100ug/vial | EUR 352.8 |
Anti-ACBP Antibody |
|||
| A01267-1 | BosterBio | 100ul | EUR 476.4 |
|
Description: Rabbit Polyclonal Antibody for ACBP Antibody (DBI) detection. Tested with WB in Human, Mouse, Rat. |
|||
Anti-PDK1 Antibody |
|||
| A01268 | BosterBio | 100ul | EUR 476.4 |
|
Description: Rabbit Polyclonal Antibody for PDK1 Antibody (PDK1) detection. Tested with WB in Human, Mouse, Rat. |
|||
Anti-CD81 Antibody |
|||
| A01281-1 | BosterBio | 100ul | EUR 476.4 |
|
Description: Rabbit Polyclonal Antibody for CD81 Antibody (CD81) detection. Tested with WB in Human, Mouse, Rat. |
|||
Anti-CHI3L1 Antibody |
|||
| A01283-1 | BosterBio | 100ug/vial | EUR 352.8 |
Anti-HLF Antibody |
|||
| A01284-1 | BosterBio | 100ug/vial | EUR 352.8 |
Anti-BRD7 Antibody |
|||
| A01289-1 | BosterBio | 100ug/vial | EUR 400.8 |
Anti-Endostatin Antibody |
|||
| A01302 | BosterBio | 100ul | EUR 476.4 |
|
Description: Rabbit Polyclonal Endostatin Antibody. Validated in IHC and tested in Human. |
|||
Anti-COL18A1 Antibody |
|||
| A01302-1 | BosterBio | 100ug/vial | EUR 352.8 |
Anti-SATB1 Antibody |
|||
| A01312-1 | BosterBio | 100ug/vial | EUR 400.8 |
Anti-TCF7 Antibody |
|||
| A01315-2 | BosterBio | 100ug/vial | EUR 352.8 |
Anti-WEE1 Antibody |
|||
| A01319-1 | BosterBio | 100ug/vial | EUR 352.8 |
Anti-CD141 Antibody |
|||
| A01325 | BosterBio | 100 ug | EUR 476.4 |
|
Description: Rabbit Polyclonal CD141 Antibody. Validated in WB and tested in Human. |
|||
Anti-NDRG1 Antibody |
|||
| A01327-1 | BosterBio | 100ug/vial | EUR 352.8 |
Anti-FOXP2 Antibody |
|||
| A01329-1 | BosterBio | 100ug/vial | EUR 352.8 |
Anti-CTRO Antibody |
|||
| A01331 | BosterBio | 100ul | EUR 476.4 |
|
Description: Rabbit Polyclonal CTRO Antibody. Validated in IHC and tested in Human. |
|||
Anti-GOLPH3 Antibody |
|||
| A01333-1 | BosterBio | 100ug/vial | EUR 400.8 |
Anti-Aladin Antibody |
|||
| A01336 | BosterBio | 100ul | EUR 476.4 |
|
Description: Rabbit Polyclonal Antibody for Aladin Antibody (AAAS) detection. Tested with WB in Human, Rat. |
|||
This will allow the belief of artificial circuits in S. oneidensis the place predictable, quantitative conduct is desired (in both single- or double-plasmid contexts). Klebsiella pneumoniae is a bacterial pathogen with rising charges of resistance to carbapenem antibiotics, however the inhabitants construction and genetic drivers of carbapenem-resistant Okay pneumoniae (CRKP) stay underexplored in creating nations. Carbapenem-resistant Okay pneumoniae had been not too long ago launched into Peru however have grown quickly in prevalence, enabling research of this pathogen because it expands into an unaffected setting.